You are here

Advanced Detection Technologies for Biochips

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R41AI060057-01
Agency Tracking Number: AI060057
Amount: $932,297.00
Phase: Phase I
Program: STTR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
2100 Central Ave Suite 106
BOULDER, CO 80301
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 KATHY ROWLEN
 (303) 449-8146
 rowlen2@colorado.edu
Business Contact
Phone: (303) 402-9100
Research Institution
 UNIVERSITY OF COLORADO AT BOULDER
 
UNIVERSITY OF COLORADO BOULDER
Boulder, CO 80309
United States

 Nonprofit College or University
Abstract

DESCRIPTION (provided by applicant): The long-term objective of the proposed work is the development of innovative detection technologies for biochips (a.k.a. DNA microarrays). It is envisioned that the proposed technologies will enable the application of biochips to biodefense, particularly when a rapid and reliable diagnostic screen is required in the field. The Specific Aims of the proposed work are 1) development of an on-chip signal amplification technique that does not require enzymes, and 2) development of an inexpensive field-portable microarray reader to be used in combination with on-chip amplification. In order to focus initial efforts we have chosen to work in conjunction with NIH funded scientists who are developing a specific application, an influenza A biochip. Because influenza A is an easily transmitted, primarily airborne pathogen, and because this virus can be genetically engineered into novel forms, it represents a serious biodefense concern. In addition, the influenza A virus has a significant impact on human health, with an estimated 500,000 and 1,000,000 deaths worldwide each year, and worldwide surveillance is essential. Finally, influenza A can serve as an excellent model system for development and thorough testing of on-chip signal amplification and a field portable microarray reader.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government